Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Fact Sheet  (GLPH)



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF


Here is the latest financial fact sheet of GLENMARK PHARMA. For more details, see the GLENMARK PHARMA quarterly results and GLENMARK PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

GLENMARK PHARMA Price History

Price Rs 1,043.7
Mkt Cap Rs m 294,520
Vol '000 20.4
P/E X -34.3
P/CF X 29.8
EPS (TTM) Rs -30.5
1 Day % -1.5
No. of shares m 282.19
1 Week % 0.8
1 Month % 12.7
1 Year % 113.0
52 week H/L Rs 1,068.0/481.1
As on Apr 18, 2024 03:33:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GLENMARK PHARMA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
GLENMARK PHARMA EQUITY SHARE DATA
High Rs712660573691487 
Low Rs484168195416349 
Sales per share (Unadj.) Rs349.6377.1387.8436.1460.4 
Earnings per share (Unadj.) Rs32.827.534.435.213.4 
Diluted earnings per shareRs32.827.534.435.213.4 
Cash flow per share (Unadj.) Rs44.342.350.152.535.0 
Dividends per share (Unadj.) Rs2.002.502.502.502.50 
Adj. dividends per shareRs2.002.502.502.502.50 
Avg Dividend yield %0.30.60.70.50.6 
Book value per share (Unadj.) Rs198.3214.7249.6321.4335.1 
Adj. book value per shareRs198.3214.6249.6321.4335.1 
Shares outstanding (eoy) m282.17282.17282.17282.17282.17 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.71.11.01.30.9 
Avg P/E ratio x18.215.011.215.731.3 
P/CF ratio (eoy) x13.59.87.710.511.9 
Price / Book Value ratio x3.01.91.51.71.2 
Dividend payout %6.19.17.37.118.7 
Avg Mkt Cap Rs m168,617116,775108,353156,067117,953 
No. of employees `000NANANANANA 
Total wages/salary Rs m20,56122,54823,43724,47427,810 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
GLENMARK PHARMA INCOME DATA
Net Sales Rs m98,655106,410109,439123,049129,901 
Other income Rs m2,0811,5965021,6673,168 
Total revenues Rs m100,736108,006109,941124,716133,069 
Gross profit Rs m17,53017,31021,28920,59415,125 
Depreciation Rs m3,2594,1724,4364,8676,113 
Interest Rs m3,3463,7733,5312,9813,496 
Profit before tax Rs m13,00610,96113,82514,4128,685 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3,7563,2014,1244,4764,911 
Profit after tax Rs m9,2507,7609,7019,9363,774 
Gross profit margin %17.816.319.516.711.6 
Effective tax rate %28.929.229.831.156.5 
Net profit margin %9.47.38.98.12.9 
GLENMARK PHARMA BALANCE SHEET DATA
Current assets Rs m66,96868,03673,59682,82398,737 
Current liabilities Rs m40,21141,26042,01046,89450,455 
Net working cap to sales %27.125.228.929.237.2 
Current ratio x1.71.61.81.82.0 
Inventory Days Days56767 
Debtors Days Days81838692115 
Net fixed assets Rs m52,09064,25567,09371,14876,920 
Share capital Rs m282282282282282 
"Free" reserves Rs m55,66460,28670,14890,42194,281 
Net worth Rs m55,94660,56870,43090,70394,563 
Long term debt Rs m35,73840,43038,88825,71738,521 
Total assets Rs m119,058132,291140,689153,972175,658 
Interest coverage x4.93.94.95.83.5 
Debt to equity ratio x0.60.70.60.30.4 
Sales to assets ratio x0.80.80.80.80.7 
Return on assets %10.68.79.48.44.1 
Return on equity %16.512.813.811.04.0 
Return on capital %17.814.615.914.99.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m62,99847,73735,75332,14246,464 
Fx outflow Rs m22,85918,88112,02313,48212,712 
Net fx Rs m40,14028,85623,72918,66033,751 
GLENMARK PHARMA CASH FLOW
From Operations Rs m 13,242 13,924 11,312 11,087 6,254 
From Investments Rs m -6,990 -7,835 -6,752 -3,333 -5,285 
From Financial Activity Rs m -7,387 -4,447 -4,418 -5,205 -775 
Net Cashflow Rs m -2,971 1,740 278 2,724 325 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 46.6%
Institution 34.8%
Non-Institution 18.6%
Total 100.0%
Free Float 53.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai - 400026
E-mail complianceofficer@glenmarkpharma.com Web www.glenmarkpharma.com
Tel Fax
Sector PHARMACEUTICALS Group Glenmark
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor Walker, Chandiok & Co.
CHM: Glenn Saldanha COMP SEC: Harish Kuber YEAR OF INC: 1977 BSE CODE: 532296 FV (Rs): 1 DIV YIELD (%): 0.2

Read: GLENMARK PHARMA 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Sensex Today Trades Higher | Just Dial Soars 10% | VST Industries, Indus Towers, ICICI Lombard Surge 5% Sensex Today Trades Higher | Just Dial Soars 10% | VST Industries, Indus Towers, ICICI Lombard Surge 5%(10:30 am)

Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.